What are the imported PD-1 drugs available?

Imported PD-1 drugs include pembrolizumab injection, nivolumab injection, and pambrolimab injection. A detailed analysis is as follows:

1. Pembrolizumab Injection

This is an anti-tumor drug that can inhibit tumor growth. Clinically, it is primarily used to treat non-small cell lung cancer, esophageal cancer, melanoma, as well as head and neck squamous cell carcinoma, colorectal cancer, and other diseases.

2. Nivolumab Injection

This is a monoclonal antibody that acts on the PD-1 receptor of T cells, promoting T cells to attack tumor cells. It is used in the treatment of various malignant tumors, such as metastatic melanoma, advanced non-small cell lung cancer, and renal cell carcinoma.

3. Pambrolimab Injection

This is a biological agent used to treat gastric cancer and breast cancer. As a monoclonal antibody drug, it targets the HER2 protein on the surface of cancer cells for targeted therapy.

In addition, other imported drugs include atezolizumab injection, avelumab injection, and dupilumab injection. It is recommended to use these medications properly under the guidance of a physician to avoid adverse effects caused by self-medication.